Med Page Today
FEBRUARY 12, 2024
(MedPage Today) -- Blood protein profiles predicted future dementia in healthy adults, a large longitudinal study showed. Blood samples from over 50,000 people in the U.K. Biobank showed that four proteins -- glial fibrillary acidic protein.
American Heart News - Heart News
FEBRUARY 12, 2024
Embargoed until 4 a.m. CT/5 a.m. ET Monday, Feb. 12, 2024 DALLAS, Feb. 12, 2024 — Dramatic advances in the understanding and treatment of cardiovascular diseases have saved millions of lives in the 100 years since the founding in 1924 of the American.
Cardiovascular Diabetology
FEBRUARY 12, 2024
Gestational diabetes mellitus (GDM) and type 2 diabetes mellitus (T2DM) share many pathophysiological factors including genetics, but whether epigenetic marks are shared is unknown. We aimed to test whether a.
American Heart News - Heart News
FEBRUARY 12, 2024
Statement Highlights: The new scientific statement highlights heart disease as the leading cause of death for women and emerging evidence that has identified several gender-specific risk factors for heart disease in women, including complications.
Med Page Today
FEBRUARY 12, 2024
(MedPage Today) -- While rapid weight-loss with bariatric surgery or drugs might temporarily worsen diabetic retinopathy as blood sugar levels are rapidly corrected, the low overall risk likely doesn't outweigh the benefits of weight loss, according.
Science Daily - Heart Disease
FEBRUARY 12, 2024
You can mend a broken heart this valentine s day now that researchers invented a new hydrogel that can be used to heal damaged heart tissue and improve cancer treatments.
HCPLive
FEBRUARY 12, 2024
Electroacupuncture demonstrates superior analgesic effects and the ability to lower serum uric acid in patients with acute gouty arthritis when compared to conventional medication options.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
HCPLive
FEBRUARY 12, 2024
The decision makes budesonide oral suspension (Eohilia) the first and only FDA-approved oral therapy for patients ≥ 11 years of age with eosinophilic esophagitis.
DAIC
FEBRUARY 12, 2024
85-year-old patient with ischemic heart disease, who underwent cardiac MRI at 3 T. A. Short-axis image from standard cine balanced SSFP breath-hold sequence. B. Short-axis image from free-breathing accelerated cine sequence with deep-learning reconstruction. Images show normal appearance of left ventricular myocardium. milla1cf Mon, 02/12/2024 - 15:06 February 12, 2024 — According to the American Journal of Roentgenology (AJR) , free-breathing cine-deep learning (DL) may yield reliable left ven
HCPLive
FEBRUARY 12, 2024
HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care to patients. At HCPLive, you will find breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight and analysis from physician contributors, and more.
DAIC
FEBRUARY 12, 2024
A team at Allina Health’s Abbott Northwestern Hospital has successfully completed the first Barostim Baroreflex Activation Therapy implant in the state of Minnesota, according to an announcement from CVRx, Inc. and Allina Health. Barostim is the world’s first FDA-approved neuromodulation heart failure device, which works by stimulating baroreceptors — natural sensors located in the wall of the carotid artery, according to CVRx.Image courtesy: CVRx christine.book Mon, 02/12/2024 - 12:58 February
Physiologically Speaking
FEBRUARY 12, 2024
Author’s note: the first 45 minutes of this episode is a discussion between myself and Dr. Vincent about results of my gait analysis. Skip to 45 minutes if you don’t want to listen to this and prefer to hear about healthy running habits and footwear. Dr.
DAIC
FEBRUARY 12, 2024
Getty Images milla1cf Mon, 02/12/2024 - 15:14 February 12, 2024 — VST Bio Corp. a leader in the development of innovative biologics to treat acute and chronic cardiovascular disease , presented data from a recent large animal study performed by VST Bio and Yale University demonstrating that a single iv bolus of VST-002 led to meaningful reduction in brain damage and improved function in an advanced model of ischemic stroke.
Science Daily - Heart Disease
FEBRUARY 12, 2024
Using the results of a standard blood test and an online tool, you can find out if you are at increased risk of having a heart attack within six months.
HCPLive
FEBRUARY 12, 2024
A new analysis cites relatively high hemoglobin levels as a protective factor for bone quality in patients with type 2 diabetes.
Dr. Smith's ECG Blog
FEBRUARY 12, 2024
A 60-something complained of vomiting, diarrhea overnight, and "bubbles in my chest" that started just prior to calling 911. He had this ECG recorded prehospital: Smith interpretation: There are hyperacute T-waves in III and aVF, and reciprocal STD in aVL with a reciprocally inverted T-wave in aVL. There are also hyperacute T-waves in V3 and V4. There is STD in V1 and V2.
Medical Xpress - Cardiology
FEBRUARY 12, 2024
Using the results of a standard blood test and an online tool, you can find out if you are at increased risk of having a heart attack within six months. The tool has been developed by a research group at Uppsala University in the hope of increasing patients' motivation to change their lifestyles.
Med Page Today
FEBRUARY 12, 2024
(MedPage Today) -- FDA staff questioned the evidence for clinical benefit with the TriClip G4 transcatheter edge-to-edge repair (TEER) system for severe tricuspid regurgitation (TR) in documents released ahead of the agency's Circulatory System.
Journal of Cardiothoracic Surgery
FEBRUARY 12, 2024
During cardiac surgery, transcranial Doppler (TCD) represents a non-invasive modality that allows measurement of red blood cell flow velocities in the cerebral arteries. TCD can also be used to detect and moni.
Circulation
FEBRUARY 12, 2024
Circulation, Ahead of Print. BACKGROUND:Cardiovascular disease is a major cause of morbidity and mortality in patients with type 2 diabetes. The effects of glucose-lowering medications on cardiovascular outcomes in individuals with type 2 diabetes and low cardiovascular risk are unclear. We investigated cardiovascular outcomes by treatment group in participants randomly assigned to insulin glargine, glimepiride, liraglutide, or sitagliptin, added to baseline metformin, in GRADE (Glycemia Reducti
Heart BMJ
FEBRUARY 12, 2024
Clinical introduction A patient in their 30s had been diagnosed with peripartum cardiomyopathy, pulmonary oedema, with severe left ventricular dysfunction at the seventh month of gestation in the third pregnancy in their late 20s. The patient had pregnancy-induced hypertension and hypothyroidism and was treated accordingly. The patient was managed medically and was referred to us in view of worsening symptoms with severe left ventricular dysfunction and moderate aortic regurgitation.
Circulation
FEBRUARY 12, 2024
Circulation, Ahead of Print. In 1924, the founders of the American Heart Association (AHA) envisioned an international society focused on the heart and aimed at facilitating research, disseminating information, increasing public awareness, and developing public health policy related to heart disease. This presidential advisory provides a comprehensive review of the past century of cardiovascular and stroke science, with a focus on the AHA’s contributions, as well as informed speculation about th
Cardiovascular Diabetology
FEBRUARY 12, 2024
Studies have demonstrated that coronary artery calcification on one hand and non-alcoholic fatty liver disease (NAFLD) on the other hand are strongly associated with cardiovascular events. However, it remains.
Frontiers in Cardiovascular Medicine
FEBRUARY 12, 2024
Introduction On-pump coronary artery bypass (ONCABG) grafting in patients with a pre-existing poor renal reserve is known to carry significant morbidity and mortality. There is limited controversial evidence on the benefit of off-pump coronary artery bypass (OPCABG) grafting in these high-risk groups of patients. We compared early clinical outcomes in propensity-matched cohorts of patients with non-dialysis-dependent pre-operative severe renal impairment undergoing OPCABG vs.
Medical Xpress - Cardiology
FEBRUARY 12, 2024
The replacement of regular salt with a salt substitute can reduce incidences of hypertension, or high blood pressure, in older adults without increasing their risk of low blood pressure episodes, according to a recent study in the Journal of the American College of Cardiology. People who used a salt substitute had a 40% lower incidence and likelihood of experiencing hypertension compared to those who used regular salt.
Frontiers in Cardiovascular Medicine
FEBRUARY 12, 2024
Primary pericardial angiosarcoma is a rare malignancy of the pericardium with variable clinical features and imaging characteristics. Herein, we report a case of histopathologically confirmed pericardial angiosarcoma in a 66-year-old man. The patient developed cardiac tamponade in a short time period. The transthoracic echocardiography showed the presence of multiple irregular echodensities, heterogeneous in echogenicity, encasing the apex of both ventricles in the pericardial space, initially m
Medical Xpress - Cardiology
FEBRUARY 12, 2024
A century ago, so little was known about heart disease that people who had it resigned themselves to years of bed rest or, worse, an early death. Even less was known about how heart disease affected women—because nobody thought it did.
Frontiers in Cardiovascular Medicine
FEBRUARY 12, 2024
Background Tongxinluo capsule (TXLC) is a common drug for treating angina pectoris of coronary heart disease (CHD). In recent years, many systematic reviews (SRs) and meta-analyses (MAs) have reported the efficacy and safety of TXLC for improving angina symptoms in patients with CHD. We aimed to comprehensively evaluate the existing SRs and MAs of TXLC in treating angina pectoris of CHD, summarize the evidence quality, and provide scientific evidence and recommendations.
DAIC
FEBRUARY 12, 2024
milla1cf Mon, 02/12/2024 - 15:18 February 12, 2024 — BIOTRONIK , a leader in implantable medical device technology, announced today they will solely supply their proprietary DX models for new single-chamber ICD implants moving forward. The move is being made in response to overwhelming recent clinical data demonstrating superior diagnostics and decreased complication risk of DX compared to traditional high-voltage systems.1-4 “Based on the current evidence, it is clear we must focus on what is p
Circulation
FEBRUARY 12, 2024
Circulation, Ahead of Print. BACKGROUND:Results from multiple randomized clinical trials comparing outcomes after intravascular ultrasound (IVUS)– and optical coherence tomography (OCT)–guided percutaneous coronary intervention (PCI) with invasive coronary angiography (ICA)–guided PCI as well as a pivotal trial comparing the 2 intravascular imaging (IVI) techniques have provided mixed results.METHODS:Major electronic databases were searched to identify eligible trials evaluating at least 2 PCI g
HCPLive
FEBRUARY 12, 2024
In an interview with HCPLive, Leesha Ellis-Cox broke down factors contributing to the bipolar disorder diagnosis gap for African Americans.
Frontiers in Cardiovascular Medicine
FEBRUARY 12, 2024
Introduction Coronary artery disease (CAD) is a highly heritable and multifactorial disease. Numerous genome-wide association studies (GWAS) facilitated the construction of polygenic risk scores (PRS) for predicting future incidence of CAD, however, exclusively in European populations. Furthermore, identifying CAD patients with elevated risks of all-cause death presents a critical challenge in secondary prevention, which will contribute largely to reducing the burden for public healthcare.
HCPLive
FEBRUARY 12, 2024
The prominent clinical investigator joins to discuss adjuvant and neoadjuvant care research, as well as the application of biomarkers in personalized care.
Frontiers in Cardiovascular Medicine
FEBRUARY 12, 2024
Background There is mounting data supporting the use of drug-coated balloons (DCB) not only for treatment of in-stent restenosis (ISR), but also in native coronary artery disease. So far, paclitaxel-coated balloons represented the mainstay DCBs. The SeQuent® crystalline sirolimus-coated balloon (SCB) (B.Braun Medical Inc, Germany) represents a novel DCB, which allows a sustained release of the limus-drug.
Becker's Hospital Review - Cardiology
FEBRUARY 12, 2024
The Association of Black Cardiologists is recruiting clinicians for a new certification program it launched in December related to hypertension management. The aim is to increase culturally conscious care for patient populations that are more likely to be diagnosed with the condition and experience adverse outcomes from it.
Frontiers in Cardiovascular Medicine
FEBRUARY 12, 2024
Takotsubo syndrome (TTS) is a rare cardiomyopathy, but its prevalence is increasing due to the greater availability of diagnostic tools, whose pathophysiology is unknown; however, the evidence points to an excess of catecholamines that ends up generating cardiac stunning. The cause of excessive sympathetic discharge is multifactorial, and some tumors may be related to their origin.
American Heart News - Heart News
FEBRUARY 12, 2024
Prohibida su divulgación hasta las 4 a.m. CT/5 a. m. ET del lunes, 12 de febrero de 2024 DALLAS, 12 de febrero de 2024 — Notables avances en la comprensión y tratamiento de las enfermedades cardiovasculares han salvado millones de vidas en los 100.
Expert insights. Personalized for you.
145 
Let's personalize your content